Stenotrophomonas maltophilia right-sided endocarditis in an adult patient with uncorrected congenital heart disease
- PMID: 31193537
- PMCID: PMC6535679
- DOI: 10.1016/j.idcr.2019.e00562
Stenotrophomonas maltophilia right-sided endocarditis in an adult patient with uncorrected congenital heart disease
Abstract
•Stenotrophomonas maltophilia is a Gram negative, low virulence, one of the leading multiple-drug-resistant pathogen and quite often causes nosocomial infection.•Bacteremia with Stenotrophomonas maltophilia has higher mortality than Pseudomonas aeruginosa.•Stenotrophomonas maltophilia endocarditis is too scarce, however, it accompanied with high rates of mortality and morbidity.•Acute bacterial endocarditis due to Stenotrophomonas maltophilia can occur even in patients with uncorrected congenital heart disease and lack of immune deficiency, therefore. clinicians should be aware.
Figures

Similar articles
-
Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia.Infect Immun. 2007 Apr;75(4):1698-703. doi: 10.1128/IAI.01469-06. Epub 2007 Jan 12. Infect Immun. 2007. PMID: 17220304 Free PMC article.
-
Characteristics of Stenotrophomonas maltophilia bacteremia in children.Pediatr Int. 2016 Feb;58(2):113-8. doi: 10.1111/ped.12745. Epub 2015 Nov 5. Pediatr Int. 2016. PMID: 26139084
-
Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.Infect Immun. 2020 Mar 23;88(4):e00855-19. doi: 10.1128/IAI.00855-19. Print 2020 Mar 23. Infect Immun. 2020. PMID: 31932329 Free PMC article.
-
Two episodes of Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve: report of a case and review of the literature.J Korean Med Sci. 2002 Apr;17(2):263-5. doi: 10.3346/jkms.2002.17.2.263. J Korean Med Sci. 2002. PMID: 11961315 Free PMC article. Review.
-
Stenotrophomonas maltophilia endocarditis.Scand J Infect Dis. 2002;34(12):925-7. doi: 10.1080/0036554021000026977. Scand J Infect Dis. 2002. PMID: 12587628 Review.
References
-
- Brooke J.S. New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen. Expert Rev Anti Infect Ther. 2014;12(January (1)):1–4. - PubMed
-
- Araoka H., Baba M., Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis. 2010;29(May (5)):605–608. - PubMed
-
- Lai C.H., Chi C.Y., Chen H.P., Chen T.L., Lai C.J., Fung C.P. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004;37:350–358. - PubMed
Publication types
LinkOut - more resources
Full Text Sources